Sort
21,281 grants matching “influenza”
Vaccine and Treatment Evaluation Units (VTEU)
$608,269Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2023 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$608,269Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2020 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$608,269Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2022 · AI
Containing Bioterroist and Emerging Infectious Diseases
$608,262Emory University · U01 · FY2004 · GM
Evolving HIV/STI risk environments of FSWs on the Mexico/U.S. Border
$608,197Kimberly C Brouwer · University Of California, San Diego · R01 · FY2011 · DA
Antimicrobial Resistant Bacteria: Exposures and Health of Cattle Workers
$607,999Joshua William Schaeffer · Colorado State University · R01 · FY2023 · OH
Lung leukocytes promote alveolar epithelial regeneration after severe injury
$607,984Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2024 · HL
Understanding and targeting fibroblast activation in influenza-triggered lung inflammation and post-viral disease
$607,981David Fielding Boyd · University Of California Santa Cruz · R01 · FY2024 · HL
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$607,735Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Effects of wildfire smoke on respiratory antiviral defense responses
$607,668Meghan Elizabeth Rebuli · Univ Of North Carolina Chapel Hill · R01 · FY2024 · ES
Designing T-cell Based HIV Vaccines using Peptide-MHC Surface Morphology
$607,604Ha Youn Lee · University Of Southern California · R01 · FY2014 · AI
Encephalitic viral infection and susceptibility to dopaminergic neurotoxins
$607,604Ronald B Tjalkens · Colorado State University · R01 · FY2020 · ES
Physician Scientist Training in Age-Related Diseases
$607,576Lona Mody · University Of Michigan At Ann Arbor · T32 · FY2023 · AG
Large-scale production and purification of biological compounds
$607,573Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2011 · DK
K-VAC: Kentucky Vaccinating Appalachian Communities
$607,507Marc T Kiviniemi · University Of Kentucky · R01 · FY2024 · MD
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing
$606,729Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2008 · AI
Development of SARS-CoV-2 nanoparticles through a plug-and-play approach
$606,667Baoshan Zhang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Immunogen Design for SARS-CoV-2
$606,666Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination
$606,664Baozhong Wang · Georgia State University · R01 · FY2018 · AI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination
$606,664Baozhong Wang · Georgia State University · R01 · FY2016 · AI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination
$606,664Baozhong Wang · Georgia State University · R01 · FY2017 · AI
Integrins, non-canonical autophagy and GC B cell response to viruses
$606,540Mridu Acharya · Seattle Children'S Hospital · R56 · FY2019 · AI
Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens
$606,473Marulasiddappa Suresh · University Of Wisconsin-Madison · U01 · FY2025 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$606,446Angelica Cifuentes Kottkamp · New York University School Of Medicine · UM1 · FY2025 · AI
Influenza virus receptors on human airway epithelial cells
$606,375James C. Paulson · Scripps Research Institute, The · R01 · FY2023 · AI